Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66643-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- ANLN antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated ANLN antibody (Cat. #66643-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Mouse, Rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1B4A8
- Vial size
- 20ul, 150ul
Submitted references CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN.
ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.
Li L, Huang K, Zhao H, Chen B, Ye Q, Yue J
Cell cycle (Georgetown, Tex.) 2020 May;19(10):1236-1252
Cell cycle (Georgetown, Tex.) 2020 May;19(10):1236-1252
LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN.
Zhang M, Wang F, Xiang Z, Huang T, Zhou WB
Clinical and experimental pharmacology & physiology 2020 Aug;47(8):1464-1472
Clinical and experimental pharmacology & physiology 2020 Aug;47(8):1464-1472
ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control.
Dai X, Mei Y, Chen X, Cai D
Frontiers in genetics 2019;10:790
Frontiers in genetics 2019;10:790
No comments: Submit comment
No validations: Submit validation data